ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1141–1152 of 2020 project topics
Cystic Fibrosis Modifier Gene Identification
Identifying genetic modifiers of CF lung disease severity including TGFB1, MUC5B, and IFRD1 for improving prognostic models.
Genetic Modifiers in Inherited Diseases Click to view more details →
Sickle Cell Disease Severity Modifier Discovery
Using GWAS for identifying genetic modifiers of SCD complications including stroke, pain crisis frequency, and acute chest syndrome risk.
Genetic Modifiers in Inherited Diseases Click to view more details →
Phenylketonuria BH4 Responsiveness Genetics
Identifying PAH allelic combinations and DHPR variants predicting tetrahydrobiopterin responsiveness for personalizing PKU treatment.
Genetic Modifiers in Inherited Diseases Click to view more details →
Huntington Disease Age of Onset Modifier Genes
Investigating DNA repair gene variants including MLH1, MSH3, and FAN1 as modifiers of HD age of onset for clinical trial stratification.
Genetic Modifiers in Inherited Diseases Click to view more details →
Hemophilia A Inhibitor Development Prediction Platform
A SaaS platform that uses genetic modifier analysis to predict which hemophilia A patients will develop inhibitors, enabling personalized treatment selection and prophylaxis strategies. This reduces costly complications and hospitalizations while enabling pharmaceutical companies to market targeted factor replacement therapies to stratified patient populations.
Genetic Modifiers in Inherited Diseases Click to view more details →
Familial Hypercholesterolemia Response Genotyping and Risk Stratification
A commercial diagnostic tool that identifies genetic modifiers affecting statin and PCSK9 inhibitor response in familial hypercholesterolemia patients for precision lipid management. Statin manufacturers and healthcare providers license this service to optimize drug selection, improving adherence rates and capturing premium reimbursement for personalized lipid therapies.
Genetic Modifiers in Inherited Diseases Click to view more details →
Beta-Thalassemia Iron Overload Modifier Gene Testing Service
An industrial-grade genetic testing platform that detects modifier genes controlling iron chelation efficiency and cardiac iron deposition in beta-thalassemia patients. Iron chelation therapy providers and specialty pharmacies monetize this service through licensing agreements and integrated treatment monitoring, expanding their patient management portfolios.
Genetic Modifiers in Inherited Diseases Click to view more details →
Duchenne Muscular Dystrophy Exon-Skipping Drug Response Biomarker Platform
A precision diagnostics platform that identifies genetic modifiers predicting response to antisense oligonucleotide and exon-skipping therapies in Duchenne muscular dystrophy. Gene therapy companies and biopharma firms integrate this biomarker into clinical protocols to increase drug approval rates and support premium pricing for responder-enriched patient cohorts.
Genetic Modifiers in Inherited Diseases Click to view more details →
Marfan Syndrome Aortic Dilation Modifier Genomic Risk Calculator
A cloud-based clinical decision support tool that quantifies aortic dissection risk using genetic modifier profiling in Marfan syndrome patients for preventive beta-blocker and ARB selection. Specialty cardiology clinics and hospital systems adopt this platform to optimize monitoring protocols, reduce emergency interventions, and support outcomes-based reimbursement models.
Genetic Modifiers in Inherited Diseases Click to view more details →
Hereditary Transthyretin Amyloidosis Organ Involvement Prediction Engine
An AI-powered commercial platform leveraging genetic modifier data to predict cardiac versus neurological phenotype progression in hereditary transthyretin amyloidosis patients. Pharmaceutical manufacturers of tafamidis and patisiran license this predictive tool to identify optimal patient populations for clinical trials and enable earlier intervention strategies that improve outcomes and market share.
Genetic Modifiers in Inherited Diseases Click to view more details →
BCR-ABL1 Fusion Detection and Monitoring
Developing sensitive RT-qPCR and ddPCR assays for BCR-ABL1 transcript quantification for CML diagnosis, therapy monitoring, and molecular remission assessment.
Genetic Basis of Lymphoma and Leukemia Click to view more details →
Lymphoma Somatic Mutation Panel Development
Creating comprehensive somatic mutation panels for NHL subtypes covering MYD88, CD79B, EZH2, and CARD11 for molecular subtype classification.
Genetic Basis of Lymphoma and Leukemia Click to view more details →